Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olmesartan vs Amlodipine Effects on Angiotensin(1-7) in T2DM
NCT05189015Phase 4Completed
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Jan 2021
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of olmesartan in hypertension (HTN), sponsored by Seoul National University Bundang Hospital. Started Jan 2021; status: completed.
02
Drugs
olmesartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT05189015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05189015.